Vivesto Ab · OMXSTO:VIVE

Vivesto Ab — Oasmia Pharmaceutical — Investor Presentation (February 2016)

6 slides from Vivesto Ab's investor presentation, Feb 26, 2016

Slide 1: Exhibit 99.1
Exhibit 99.1
Slide 2: Executive Summary
Oasmia Pharmaceutical AB e Vallongatan 1 e SE-752 28 Uppsala am la Sweden Tel +46 18 50 54 40 Wwww.oasmia.com Executive Summary Oasmia Pharmaceutical AB (NASDAQ: OASM) is a Swedish biotechnology Company that develops and manufactures a new generation of chemotherapy drugs in the field of both human
Slide 3: Executive Summary
Oasmia Pharmaceutical AB Vallongatan 1 SE-752 28 Uppsala Sweden Tel +46 18 50 54 40 www.oasmia.com Executive Summary Oasmia Pharmaceutical AB (NASDAQ: OASM) is a Swedish biotechnology Company that develops and manufactures a new generation of chemotherapy drugs in the field of both human and veterin
Slide 4: Slide 4
Slide 5: Management
Management Julian Aleksov, Executive Chairman Executive Chairman of the Board since 2015, Member of the Board since 1999. Former CEO of Oasmia and one of the founders of the company. Has extensive experience in coordination of research projects and strategic development of global intangible assets.
Slide 6: Management
Management Julian Aleksov, Executive Chairman Executive Chairman of the Board since 2015, Member of the Board since 1999. Former CEO of Oasmia and one of the founders of the company. Has extensive experience in coordination of research projects and strategic development of global intangible assets.